#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Oesophageal adenocarcinoma Hypergammaglobulinaemia benign monoclonal Craniopharyngioma Synovial sarcoma recurrent Metastases to central nervous system Urethral valves Metabolic disorder Neurotrophic keratopathy Chronic inflammatory demyelinating polyradiculoneuropathy Acute graft versus host disease in liver Fms-like tyrosine kinase 3 positive Cardiac failure acute Waldenstrom's macroglobulinaemia Myelofibrosis B-cell lymphoma refractory More trials…

    Learn about Rare Diseases

    Immunodeficiency congenital – Diagnostics Hereditary angioedema Lysosomal storage disorder – Treatment Choroid melanoma – Life with Disease Alport’s syndrome Andersen-Tawil syndrome – Treatment Arterial tortuosity syndrome – Treatment Chordoma – Life with Disease Angiosarcoma non-metastatic – Treatment Propionic acidaemia – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Vx-670 Methadone Hydrochloride Aminohippuric Acid Bbp-398 Anhydrous Cholestyramine Teicoplanin Ipilimumab Lolium Perenne Metamizole Ganciclovir Sodium Apixaban Ioflupane (123I) Cabergoline SGN-ALPV Mifepristone Verapamil Hydrochloride Eletriptan ICEF15 Ulipristal Acetate Inupadenant Hydrochloride More therapies…

    Learn about Your Condition

    Arthritis infective Hyponatraemia Cervix carcinoma stage II Embolism venous Poor quality sleep Urinary tract infection Osteosarcoma Craniosynostosis Thrombectomy Syphilis Staphylococcal infection Cervix carcinoma stage IV Ependymoma Hepatic angiosarcoma Compulsive sexual behaviour More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on the Effectiveness of Sirolimus and Trametinib for Treating Diffuse Intrinsic Pontine Glioma in Children Aged 3-18 Years

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Brain stem glioma
    Investigated Drugs:
    • Sirolimus
    • Trametinib
    Poland

  • Study on Atezolizumab for Patients with Malignant Pleural Mesothelioma After Surgery

    Recruiting

    3 1 1
    Investigated Diseases:
    • Pleural mesothelioma malignant
    Investigated Drugs:
    • Atezolizumab
    Italy

  • Study on Using Gentamicin and Clindamycin to Prevent Abscesses After Surgery for Complicated Appendicitis in Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Appendicitis perforated
    • Complicated appendicitis
    • Peritoneal abscess
    Investigated Drugs:
    • Gentamicin
    • Clindamycin
    The Netherlands

  • Study on Optimizing Ravulizumab Dosing for Adults with Paroxysmal Nocturnal Hemoglobinuria (PNH)

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Paroxysmal nocturnal haemoglobinuria
    Investigated Drugs:
    • Ravulizumab
    The Netherlands

  • Study to Optimize Cytokine Release Syndrome for Glofitamab with Gemcitabine and Oxaliplatin in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma

    Recruiting

    2 1 1 1
    France Germany Italy

  • Study on the Effectiveness of Dermatophagoides Allergen Extracts and Histamine Dihydrochloride for Patients with Allergies

    Recruiting

    2 1 1
    Investigated Diseases:
    • Hypersensitivity
    Investigated Drugs:
    • Dermatophagoides Farinae
    • Dermatophagoides Pteronyssinus
    • Histamine Dihydrochloride
    Spain
Previous Page
1 … 270 271 272 273 274 … 1,648
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!